SAM
Senzar Asset Management Portfolio holdings
AUM
$34.7M
This Quarter Return
-17.71%
1 Year Return
+0.55%
3 Year Return
-0.75%
5 Year Return
–
10 Year Return
–
AUM
$504M
AUM Growth
+$504M
(-44%)
Cap. Flow
-$280M
Cap. Flow
% of AUM
-55.63%
Top 10 Holdings %
Top 10 Hldgs %
63.87%
Holding
48
New
7
Increased
17
Reduced
13
Closed
11
Top Buys
| 1 |
Amgen
AMGN
|
$40.4M |
| 2 |
Elevance Health
ELV
|
$28.5M |
| 3 |
SHPG
Shire pic
SHPG
|
$20.7M |
| 4 |
Labcorp
LH
|
$14.9M |
| 5 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$6.08M |
Top Sells
| 1 |
Bausch Health
BHC
|
$132M |
| 2 |
Viatris
VTRS
|
$42.5M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$38.7M |
| 4 |
AET
Aetna Inc
AET
|
$37.7M |
| 5 |
STJ
St Jude Medical
STJ
|
$31.3M |
Sector Composition
| 1 | Healthcare | 88% |
| 2 | Financials | 4.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACOR
26
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $4.89M | 0.97% |
184,902
-319,351
| -63% | -$8.45M |
|
|
LCI
27
DELISTED
Lannett Company, Inc.
LCI
| $4.87M | 0.97% |
+271,600
| New | +$4.87M |
|
|
ARNA
28
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $4.09M | 0.81% |
2,076,091
+132,000
| +7% | +$260K |
|
29
Eledon Pharmaceuticals
ELDN
$155M
| $3.57M | 0.71% |
+637,110
| New | +$3.57M |
|
30
Rigel Pharmaceuticals
RIGL
$697M
| $3.36M | 0.67% |
1,616,200
+102,700
| +7% | +$214K |
|
|
VXRT
31
DELISTED
Vaxart
VXRT
| $3.06M | 0.61% |
2,040,176
+129,700
| +7% | +$195K |
|
|
NDRM
32
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $3.04M | 0.6% |
215,400
+13,700
| +7% | +$193K |
|
|
KDNY
33
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $2.74M | 0.54% |
+213,680
| New | +$2.74M |
|
|
AGRX
34
DELISTED
Agile Therapeutics, Inc
AGRX
| $2.56M | 0.51% |
412,869
+26,300
| +7% | +$163K |
|
|
ZGNX
35
DELISTED
Zogenix, Inc.
ZGNX
| $2.48M | 0.49% |
268,600
-109,000
| -29% | -$1.01M |
|
|
SIEN
36
DELISTED
Sientra, Inc.
SIEN
| $2.15M | 0.43% |
314,066
-266,785
| -46% | -$1.82M |
|
|
ADYX
37
DELISTED
Adynxx, Inc. Common Stock
ADYX
| $579K | 0.12% |
706,091
-308,012
| -30% | -$253K |
|
|
AVDL
38
Avadel Pharmaceuticals
AVDL
$1.43B
| – | – |
-441,500
| Closed | -$5.39M |
|
|
39
Bausch Health
BHC
$2.74B
| – | – |
-1,299,056
| Closed | -$132M |
|
40
Biogen
BIIB
$19.4B
| – | – |
-86,300
| Closed | -$26.4M |
|
41
Centene
CNC
$14.3B
| – | – |
-260,000
| Closed | -$17.1M |
|
42
DaVita
DVA
$9.85B
| – | – |
-94,800
| Closed | -$6.61M |
|
43
Esperion Therapeutics
ESPR
$448M
| – | – |
-223,700
| Closed | -$4.98M |
|
|
44
Viatris
VTRS
$12.3B
| – | – |
-785,284
| Closed | -$42.5M |
|
|
FPRX
45
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| – | – |
-135,535
| Closed | -$5.62M |
|
|
MNK
46
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| – | – |
-291,940
| Closed | -$21.8M |
|
|
SPNC
47
DELISTED
Spectranetics Corp
SPNC
| – | – |
-1,092,512
| Closed | -$16.5M |
|
|
STJ
48
DELISTED
St Jude Medical
STJ
| – | – |
-506,900
| Closed | -$31.3M |
|